Back

Myosin inhibitors as novel drugs for hypertrophic cardiomyopathy

1 September 2024 (14:00 - 14:15)
Organised by: Logo
Congress Presentation Part of: New treatment targets for personalised therapy in genetic cardiomyopathies Cardiomyopathies ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Jolanda van der Velden

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Myosin activators for cardiomyopathy: all is not lost
Professor Z. Papp (Debrecen, HU)
Slides Video
Presentation thumbnail
Targeting desmosomal adhesion to treat arrhythmogenic cardiomyopathy
Assistant Professor C. Schinner (Bern, CH)
Slides Video
Presentation thumbnail
Targeting titin in dilated cardiomyopathy
Professor W. Linke (Muenster, DE)
Slides Video
Presentation thumbnail
New treatment targets for personalised therapy in genetic cardiomyopathies - discussion
Video

Access the full session

Session thumbnail
New treatment targets for personalised therapy in genetic cardiomyopathies
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Myosin inhibitors in hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Understanding the aetiology of HCM and pathways for intervention

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources